JP Morgan Chase & Co’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.8M | Buy |
|
|||||
|
2025
Q2 | $34.8M | Buy |
|
|||||
|
2025
Q1 | $27.7M | Sell |
|
|||||
|
2024
Q4 | $35.9M | Sell |
|
|||||
|
2024
Q3 | $116M | Sell |
|
|||||
|
2024
Q2 | $83.3M | Sell |
|
|||||
|
2024
Q1 | $156M | Sell |
|
|||||
|
2023
Q4 | $195M | Sell |
|
|||||
|
2023
Q3 | $165M | Buy |
|
|||||
|
2023
Q2 | $178M | Buy |
|
|||||
|
2023
Q1 | $180M | Buy |
|
|||||
|
2022
Q4 | $150M | Sell |
|
|||||
|
2022
Q3 | $210M | Sell |
|
|||||
|
2022
Q2 | $187M | Sell |
|
|||||
|
2022
Q1 | $198M | Buy |
|
|||||
|
2021
Q4 | $169M | Sell |
|
|||||
|
2021
Q3 | $192M | Sell |
|
|||||
|
2021
Q2 | $132M | Sell |
|
|||||
|
2021
Q1 | $141M | Buy |
|
|||||
|
2020
Q4 | $105M | Sell |
|
|||||
|
2020
Q3 | $85.5M | Buy |
|
|||||
|
2020
Q2 | $46.2M | Buy |
|
|||||
|
2020
Q1 | $35.2M | Buy |
|
|||||
|
2019
Q4 | $57.2M | Buy |
|
|||||
|
2019
Q3 | $45M | Buy |
|
|||||
|
2019
Q2 | $37.6M | Sell |
|
|||||
|
2019
Q1 | $94.1M | Buy |
|
|||||
|
2018
Q4 | $142M | Sell |
|
|||||
|
2018
Q3 | $204M | Buy |
|
|||||
|
2018
Q2 | $147M | Sell |
|
|||||
|
2018
Q1 | $105M | Sell |
|
|||||
|
2017
Q4 | $91.9M | Buy |
|
|||||
|
2017
Q3 | $136M | Buy |
|
|||||
|
2017
Q2 | $138M | Buy |
|
|||||
|
2017
Q1 | $113M | Buy |
|
|||||
|
2016
Q4 | $33.6M | Buy |
|
|||||
|
2016
Q3 | $52.8M | Buy |
|
|||||
|
2016
Q2 | $25.7M | Buy |
|
|||||
|
2016
Q1 | $13.6M | Buy |
|
|||||
|
2015
Q4 | $11.2M | Buy |
|
|||||
|
2015
Q3 | $14.6M | Buy |
|
|||||
|
2015
Q2 | $17.6M | Buy |
|